About
Small molecules, diagnostics, skin care
Areas of Focus
Categories
DiagnosticsSmall Molecule PharmaceuticalJapan
Clinical Trials (18)
View allTotal Trials
18
As Lead Sponsor
12
As Collaborator
6
Total Enrollment
21,733
By Phase
PHASE3: 9PHASE1: 5PHASE2: 2PHASE4: 1
By Status
COMPLETED: 17UNKNOWN: 1
Clinical Trials Pipeline18 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT04345471Lead Sponsor
A Study of MD-120 in Patients With Depression
PHASE3Completed
615 participants
Started: May 18, 2020 · Completed: Sep 14, 2022
NCT04239950Lead Sponsor
Efficacy of Ethyl Icosapentate in Patients With Severe Hypertriglyceridemia
PHASE3Completed
316 participants
Started: May 9, 2020 · Completed: Jul 20, 2023
NCT04221217Lead Sponsor
Long-term Safety and Efficacy Study of MND-2119 in Patients With Hypertriglyceridemia
PHASE3Completed
120 participants
Started: Feb 14, 2020 · Completed: Jul 14, 2021
NCT03693131Lead Sponsor
Efficacy of MND-2119 in Participants With Hypertriglyceridemia
PHASE3Completed
580 participants
Started: Oct 27, 2018 · Completed: Jun 29, 2019
NCT03372200Lead Sponsor
Febuxostat-Controlled, Double-Blind, Comparative Study of FYU-981 in Hyperuricemia With or Without Gout
PHASE3Completed
203 participants
Started: Jan 9, 2018 · Completed: Jul 5, 2018
Locations (1)
Headquarters
Tokyo, Japan
Map
Loading map...